Intensity Therapeutics Stock (NASDAQ: INTS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 12.02K |
Day Range | - - - |
52 Wk Range | 2.01 - 11.44 |
Market Cap | $53.71M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 0.24% |
Days to Cover | 4.91 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Intensity Therapeutics (NASDAQ:INTS) through any online brokerage.
Other companies in Intensity Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX) and Eagle Pharmaceuticals (NASDAQ:EGRX).
Intensity Therapeutics has a consensus price target of $12.00.
The stock price for Intensity Therapeutics (NASDAQ: INTS) is $3.9 last updated September 20, 2024 at 4:16 PM EDT.
There are no upcoming dividends for Intensity Therapeutics.
Intensity Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Intensity Therapeutics.
Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.